Subject Management Discussion and Analysis for the second quarter ended 30 June 2020 Attention President The Stock Exchange of Thailand According to the resolution of the Board of Directors of JAS Asset
EKH/CS/2020/030 11 August 2020 Subject: Management Discussion and Analysis for the Second Quarter 2020 results To Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public
[COMPANY NAME] Ref.: EFORL IR037/2020 September 11, 2020 Subject: Management Discussion and Analysis Quarter 2 Ending 30 June 2020 To President The Stock Exchange of Thailand 1. Overview financial
MD&A Q3_2020 (Eng ) November 2, 2020 Subject : Interim Management Discussion and Analysis of Q3/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial
April 27th, 2021 No. ACC/HO 008/64 Topic: Management Discussion and Analysis for the Quarter of 1/2021 To: President The Stock Exchange of Thailand During the first quarter of 2021 a new wave of
MDA Q3_2019 (Eng ) November 8, 2019 Subject : Interim Management Discussion and Analysis of Q3/2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
1 Ref. No. IVL 005/02/2018 20 Feb 2018 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of Indorama
suitability for investment and the relevant risk exposure. The effectiveness of this registration statement neither represents that the Ministry of Finance of Thailand, the Securities and Exchange Commission or
กรุงเทพฯ 10330 โทร 02 654 3344 โทรสาร 02 654 3323 ทะเบียนเลขท่ี 0107554000232 No. PACE-L19/2018 Date 10 April 2018 Subject Acquisition and Disposition of Assets To: President Stock Exchange of Thailand